✨ Check out this insightful post from TechCrunch 📖 📂 **Category**: TC,AI,Elon Musk,OpenAI trial 📌 **What You’ll Learn**: Elon Musk's claim that he was mistreated by OpenAI's founders has failed after nine jurors in California unanimously decided that his lawsuits were filed too late. Musk took Sam Altman, Greg Brockman, OpenAI, and Microsoft to “steal charity” by creating a for-profit subsidiary of the Frontier AI Laboratory. However, jurors found that any damages Musk suffered came before the deadline to file his claims under the law. While the trial delved into OpenAI's melodramatic history and featured testimony from prominent Silicon Valley…
✨ Check out this must-read post from TechCrunch 📖 📂 **Category**: Security,cyberattack,cybersecurity,data breach,healthcare,new york city 📌 **What You’ll Learn**: New York public health provider NYC Health and Hospitals says a months-long data breach that allowed hackers to steal personal data, medical records and fingerprint scans affects at least 1.8 million people. NYCHHC is the largest public health system in the United States and provides health care to more than one million New Yorkers, most of whom are uninsured or receiving government health care benefits, such as Medicaid. The healthcare system reported this number to the US Department of Health and…
💥 Check out this must-read post from TechCrunch 📖 📂 **Category**: Apps,ai scribe,Health tech,Kin Health,maveron 💡 **What You’ll Learn**: The market for AI-based note-taking devices has seen significant expansion in the United States, with the category generating more than $600 million in revenue last year, according to a Menlo Ventures report. As startups like Heidi Health and Freed have shown, there is good demand for this technology in the healthcare space, as doctors and clinics see the potential of an AI assistant that can help them track patient conversations, view health records, and reduce their administrative burdens. But these apps…
🔥 Check out this insightful post from TechCrunch 📖 📂 **Category**: AI,Media & Entertainment,alexa plus,alexa+,Amazon,Generative AI,podcasts ✅ **What You’ll Learn**: Amazon announced the latest update to Alexa+ on Monday: the ability to create on-demand podcast episodes. The new feature, called Alexa Podcasts, is rolling out to customers in the US today. Amazon describes the ability as a way to "turn any topic you're curious about into a podcast episode, ready in minutes." To use this feature, all users have to do is ask Alexa+ to create a podcast about a topic they're interested in. Users don't need to upload documents,…
🔥 Explore this awesome post from TechCrunch 📖 📂 **Category**: Security,cyberattack,cybersecurity,data breach,extortion,grafana,open source 💡 **What You’ll Learn**: Grafana Labs, the maker of its popular open source web visualization software, confirmed it had been hacked but refused to pay hackers who threatened to release the company's database. In a series of posts on social media, the lab said its investigation found that hackers had misused stolen token credentials allowing access to the company's GitLab environment, which it uses to develop code. The code did not provide access to customer records or financial data, but it did allow hackers to obtain company…
💥 Explore this must-read post from WIRED 📖 📂 **Category**: Science,Viral Content 📌 **What You’ll Learn**: Anyone who has Chickenpox had one distinct memory: a constant, all-consuming itch.Ciara DeVita was only 3 years old when she contracted the virus, but she remembers it well, as well as the oven mitts she was forced to wear to prevent herself from getting scratched. She also recalls being taken to hang out with her cousin while covered in blisters, in the hopes of deliberately infecting them both.Devita, now 30, was the second in the chain, having been taken in by her parents for…
🔥 Discover this must-read post from TechCrunch 📖 📂 **Category**: Startups,Hardware,AI,optics,SMART Glasses,ai glasses,LetinAR,optics technology 📌 **What You’ll Learn**: Imagine you are riding a motorcycle at 160 kilometers per hour when an arrow appears floating on the road in front of you, telling you exactly where to go. No phone, no dashboard. Just your helmet and a thumbnail sized lens. This is not a concept video. It's headed to European roads early this year. This is an early glimpse of where smart glasses are headed. Over the past few years, big tech companies have been quietly (and not very quietly) placing…
💥 Discover this trending post from WIRED 📖 📂 **Category**: Science,Science / Health,Super Cells 💡 **What You’ll Learn**: Miracle cancer A treatment that involves engineering a patient's own immune cells is being repurposed to treat HIV, and early results from two people suggest it holds promise for controlling the virus in the long term.As part of a clinical trial, scientists took people's own immune cells and reprogrammed them in the laboratory to recognize and attack HIV in the body. After a single injection of the modified cells, two people with HIV had undetectable levels of the virus, one for about…
🔥 Check out this insightful post from Ars Technica 📖 📂 **Category**: AI,Policy,cftc,Kalshi,polymarket,prediction markets,syndication 📌 **What You’ll Learn**: For much of the past year, it seemed as if prediction markets had ushered in a new golden age of fraud. At Polymarket, traders made fortunes from suspiciously timed bets on geopolitical events such as the raid on Venezuela and the Iran war. It was unclear whether the US government would be interested in going after some of the more obvious bad actors, given that Polymarket's cryptocurrency-based platform was technically offshore and not regulated or licensed within the country. However, now, the…
🔥 Discover this insightful post from Ars Technica 📖 📂 **Category**: Health,Science,autoimmune disease,cancer treatment,syndication,targeted cancer treatments ✅ **What You’ll Learn**: Causing a secondary cancer may be an acceptable risk when treating a life-threatening cancer, but perhaps not in an autoimmune setting, says Matt Lunning, MD, medical director of gene and cell therapy at Nebraska Medicine in Omaha. How to balance the risks between the effects of autoimmune diseases, the severity of which can range widely, and the difficult-to-measure risks of future side effects or cancers remains a major open question. Researchers are already working on second- and third-generation versions of…
